Why the study?
Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
Population
Patients after myocardial infarction with average cholesterol levels
Authors
Loading...
Supports broader statin use post-MI; extends secondary prevention evidence to average-cholesterol populations.
Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
Pravastatin provides clinical benefit in reducing coronary events for post-myocardial infarction patients even when their cholesterol levels are average.
Sacks et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: